EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder ( ARFID ) Symptoms in the Adult General Population of the UK and USA

Grace Brownlow, Rosie Flack, Helen Burton-Murray iD, Olafur Palsson, Imran Aziz iD

International Journal of Eating Disorders · 2026-02 · 59 (2) · 362-370

DOI: 10.1002/eat.24588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Eating Disorders, online erschienen am 29.10.2025. Verfasst von Grace Brownlow und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. Hauptthemen laut MEDLINE: Avoidant Restrictive Food Intake Disorder, Cost of Illness. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, (K23 DK131334-HBM), Tillotts Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Avoidant/Restrictive Food Intake Disorder (ARFID) is a feeding and eating disorder characterized by avoidant/restrictive eating behaviors that lead to medical and/or functional impairments. While ARFID is increasingly recognized within pediatric populations and specialist clinics, data on its prevalence and burden within the adult general population remain sparse. We sought to address this knowledge gap.

Methods

We conducted a population‐based internet survey with predefined demographic quotas across the UK and USA. The survey included the Nine‐Item ARFID Screen (NIAS), the Rome IV diagnostic questionnaire for disorders of gut‐brain interaction (e.g., irritable bowel syndrome, functional dyspepsia), and questions regarding demographics, body mass index, somatic symptoms, anxiety and depression, quality of life, and healthcare utilization.

Results

Among 4002 participants (mean age 47.1 years, 50% female), 26.0% screened positive for ARFID. Prevalence was significantly higher in females versus males (29.6% vs. 22.1%, OR 1.48, 95% CI 1.28–1.71) and varied by age: 18–39 years (31.6%), 40–64 years (25.0%), and ≥ 65 years (16.1%; p < 0.001). Participants with a positive ARFID screen demonstrated significantly higher rates of underweight status, disorders of gut‐brain interaction, mood disturbances, somatic symptoms, reduced mental and physical quality of life, and increased healthcare utilization compared to unaffected individuals. Increasing severity of ARFID correlated with greater general health impairment (all p < 0.001).

Conclusion

A positive ARFID screen is common within the adult general population, affecting 1‐in‐4 people, and associated with a substantial health burden. Increased awareness of ARFID will facilitate clinical service provision and guide future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Avoidant Restrictive Food Intake DisorderCost of IllnessHumansMaleFemaleAdultMiddle AgedUnited KingdomPrevalenceUnited StatesYoung AdultAdolescentQuality of LifeAged

Stichwörter der Autor:innen

ARFIDNIASmultimorbidity

Autor:innen und Institutionen

  • Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
  • Academic Department of Gastroenterology, Sheffield Teaching Hospitals, Sheffield, UK.
  • Department of Medicine, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Center for Functional GI and Motility Disorders, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID-Profile: Helen Burton-Murray, Imran Aziz

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases, (K23 DK131334-HBM)
  • Tillotts Pharma
  • Novonesis
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Brownlow, G., Flack, R., Burton-Murray, H., Palsson, O., & Aziz, I. (2026). The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder ( ARFID ) Symptoms in the Adult General Population of the UK and USA. International Journal of Eating Disorders, 59(2), 362-370. https://doi.org/10.1002/eat.24588

Vancouver

Brownlow G, Flack R, Burton-Murray H, Palsson O, Aziz I. The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder ( ARFID ) Symptoms in the Adult General Population of the UK and USA. International Journal of Eating Disorders. 2026;59(2):362-370. doi:10.1002/eat.24588

BibTeX
@article{Brownlow2026,
  author = {Brownlow, Grace and Flack, Rosie and Burton-Murray, Helen and Palsson, Olafur and Aziz, Imran},
  title = {The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder ( ARFID ) Symptoms in the Adult General Population of the UK and USA},
  journal = {International Journal of Eating Disorders},
  year = {2026},
  volume = {59},
  number = {2},
  pages = {362--370},
  doi = {10.1002/eat.24588}
}
Kostenlos starten →